InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

49
Insider
Date
Role
Action
Shares
Price
Amount
Jeff Cislini
25 Sep 2026
SVP & General Counsel
Sold on a plan
765
$207.32
$158.60K
Anthony Mancini
24 Sep 2026
See Remarks
Sold on a plan
587
$200.00
$117.40K
Anthony Mancini
18 Sep 2026
See Remarks
Sold on a plan
1,764
$196.94
$347.40K
Jack Anders
16 Sep 2026
Chief Financial Officer
Sold on a plan
3,992
$199.30
$795.62K
Jack Anders
16 Sep 2026
Chief Financial Officer
Sold on a plan
61
$195.00
$11.90K
Jeff Cislini
16 Sep 2026
SVP & General Counsel
Sold on a plan
3,314
$199.30
$660.49K
Jeff Cislini
16 Sep 2026
SVP & General Counsel
Sold on a plan
52
$195.01
$10.14K
Mark A Goldsmith
16 Sep 2026
See Remarks
Sold on a plan
13,775
$199.30
$2.75M
Mark A Goldsmith
16 Sep 2026
See Remarks
Sold on a plan
213
$195.01
$41.54K
Margaret A Horn
16 Sep 2026
Chief Operating Officer
Sold on a plan
4,891
$199.30
$974.79K
Margaret A Horn
16 Sep 2026
Chief Operating Officer
Sold on a plan
76
$195.01
$14.82K
Stephen Michael Kelsey
16 Sep 2026
See Remarks
Sold on a plan
5,484
$199.30
$1.09M
Stephen Michael Kelsey
16 Sep 2026
See Remarks
Sold on a plan
85
$195.01
$16.58K
Alan B. Sandler
16 Sep 2026
Chief Development Officer
Sold on a plan
336
$199.30
$66.97K
Alan B. Sandler
16 Sep 2026
Chief Development Officer
Sold on a plan
5
$194.96
$974.79
Anthony Mancini
16 Sep 2026
See Remarks
Sold on a plan
1,747
$199.30
$348.18K
Anthony Mancini
16 Sep 2026
See Remarks
Sold on a plan
27
$195.05
$5.27K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
371
$212.27
$78.75K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
3,844
$211.36
$812.46K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
4,730
$210.50
$995.68K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
2,853
$209.56
$597.87K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
3,587
$208.55
$748.08K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
999
$207.33
$207.12K
Lorence H. Kim
8 Sep 2026
Director
Sold on a plan indirect
706
$206.60
$145.86K
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
625
$206.15
$128.85K
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
2,128
$205.19
$436.64K
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
7,271
$204.35
$1.49M
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
26,160
$203.55
$5.32M
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
12,919
$202.48
$2.62M
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
6,597
$201.47
$1.33M
Lorence H. Kim
31 Aug 2026
Director
Sold on a plan indirect
300
$200.56
$60.17K
Stephen Michael Kelsey
16 Jun 2026
See Remarks
Sold on a plan
4,175
$156.12
$651.80K
Jack Anders
16 Jun 2026
Chief Financial Officer
Sold on a plan
2,722
$156.12
$424.96K
Jeff Cislini
16 Jun 2026
General Counsel
Sold on a plan
2,157
$156.12
$336.75K
Mark A Goldsmith
16 Jun 2026
See Remarks
Sold on a plan
10,020
$156.12
$1.56M
Jeff Cislini
19 Mar 2026
General Counsel
Sold on a plan
1,163
$97.44
$113.32K
Xiaolin Wang
17 Mar 2026
See Remarks
Sold on a plan
2,010
$99.48
$199.96K
Jeff Cislini
17 Mar 2026
General Counsel
Sold on a plan
1,795
$99.48
$178.57K
Jack Anders
17 Mar 2026
Chief Financial Officer
Sold on a plan
2,753
$99.48
$273.87K
Margaret A Horn
17 Mar 2026
Chief Operating Officer
Sold on a plan
4,583
$99.48
$455.92K
Mark A Goldsmith
17 Mar 2026
See Remarks
Sold on a plan
12,871
$99.48
$1.28M
Stephen Michael Kelsey
17 Mar 2026
See Remarks
Sold on a plan
4,302
$99.48
$427.96K
Lin Wei
17 Mar 2026
Chief Medical Officer
Sold on a plan
2,073
$99.48
$206.22K
Jeff Cislini
21 Jan 2026
General Counsel
Sold on a plan
908
$115.60
$104.96K
Jack Anders
16 Dec 2025
Chief Financial Officer
Sold on a plan
3,104
$77.09
$239.29K
Margaret A Horn
16 Dec 2025
Chief Operating Officer
Sold on a plan
4,847
$76.82
$372.33K
Stephen Michael Kelsey
16 Dec 2025
See Remarks
Sold on a plan
5,447
$76.82
$418.42K
Mark A Goldsmith
16 Dec 2025
See Remarks
Sold on a plan
15,394
$76.82
$1.18M
Jeff Cislini
16 Dec 2025
General Counsel
Sold on a plan
2,688
$76.82
$206.48K
Show all 160 transactions →

What was left out

Form 4 filings counted 70
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 49
Sales straight out of an exercise 109
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,241,674
History held since 14 Feb 2020